⌘K

Login Start Free

Home/Filings/4/0001179110-14-002276

4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-14-002276

CIK 0001360886operating

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 9:34 AM ET

Size

7.0 KB

Accession

0001179110-14-002276

Insider Transaction Report

Form 4

Period: 2014-02-06

OSIRIS THERAPEUTICS, INC.OSIR

Debrabandere Lode

Vice President

Transactions

Award
Incentive Stock Option (right to buy)
2014-02-06$14.93/sh+10,199$152,271→ 232,699 total
Exercise: $14.93From: 2015-02-06Exp: 2024-02-06→ Common Stock (10,199 underlying)
Award
Non-Qualified Stock Option (right to buy)
2014-02-06$14.93/sh+139,801$2,087,229→ 372,500 total
Exercise: $14.93From: 2015-02-06Exp: 2024-02-06→ Common Stock (139,801 underlying)

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeoperating

IncorporatedMD

Related Parties

1

filerCIK 0001360886

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 9:34 AM ET
Size: 7.0 KB

View on SEC.gov